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Epilepsy is a chronic neurological disease with an annual
incidence rate of 40-70 per 100.000 population, affecting 0.5-
1.0% of women of childbearing age. Epilepsy in reproductive-
aged and pregnant women rise a number of questions like
interaction of antiepileptic drugs (AEDs) with contraceptives,
changes in fertility, pregnancy and hormonal modification, a
series of risks for congenital malformations caused by AEDs,
and obstetric and lactation issues that require knowledge and
recommendations for an adequate control of epileptic seizures
in women with epilepsy. Pregnant women with epilepsy has
substantially increased risk of preeclampsia, preterm labor,
stillbirth, cesarean delivery, and a more than 10-fold increased
risk of death. The risk for status epilepticus during pregnancy
is about 1–2%.
We aimed to establish peculiarities of epilepsy in women in
Moldova and to analyze the impact of the disease on their life
and health.
We runned a retrospective study (medical records) of women consulted at National Center for
Epilepsy during 2015-2020 years. Demographic data, diagnosis, clinical and paraclinical data,
obstetric history, antiepileptic therapy, adherence and effectiveness of treatment,
psychoneurological profile were analyzed.
About 1162 (68,8%) women from 1688 included in study were of
childbearing age, 77.2% of them on antiepileptic monotherapy or no
AED treatment. More than a half of women (55,3%) presented
comorbidities, structural epilepsy (53,4%) with predominantly focal
seizures (66,5%). About 6% (106 patients) presented with acute
seizures of unknown or induced genesis. Standard Video EEG
investigation show no abnormalities in almost half of women
included in study - 810 (48%). In 186 women (11%) a correlation
between the occurrence of seizures and the menstrual cycle was
found. 11% (185) of patients have been non-compliant with
antiepileptic treatment, 2% (34) of whom developed Status
epilepticus. More than a half of 162 pregnant women (108(66,7%)) did
not present seizures during pregnancy; only 3 (1,8%) has seizures
during labor. 70 women (44,9%) underwent caesarean section, more
than a half of them - 41 (58,6%) being emergencies. Only 31(44,3%)
has obstetric indications, while 17 (24,3%) has neurological or mixed
indications 22 (31,4%). Most of pregnant women with clinical
remission at least 9 months to 1 year before pregnancy (89%) did
not develop seizures. During pregnancy, 69% were on antiepileptic
treatment, 98 (87,5%) on monotherapy. One case of status
epilepticus during pregnancy and one case of congenital spina bifida
malformation in a child born by mother on antiepileptic polytherapy
has been documented.
 Women with epilepsy face challenges caused by the influences of
hormonal changes on seizure activity and endocrine function.
 Antiepileptic drugs influences contraception, pregnancy and
lactation.
 Mental health issues are common in women with epilepsy,
affecting their health and social life.
 Adherence to therapy, including during pregnancy and birth, are
important to avoid complications.
 Malformations due to AEDs are rare.
 Complications due to treatment non-compliance are significant
and request counselling and educating women with epilepsy,
including pregnancy and birth issues
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Figure 5. Addressability according to the region of the country
Figure 1 Summary of clinically relevant issues in women with epilepsy.
Abbreviations: AED=antiepileptic drug; PCOS=polycystic ovary syndrome; OCP=oral contraceptive pill 
from Bangar S, Shastri A, El-Sayeh H, Cavanna AE. Women with epilepsy: clinically relevant issues. Funct Neurol. 
2016;31(3):127-134. doi:10.11138/fneur/2016.31.3.127
Figure 6. Stratification of study group according to medication
Figure 2. Repartition by type of seizures and etiology
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Figure 4. Place of residence
Figure 7. Psychiatric symptoms(Depression and Anxiety)
Figure 3. Age groups
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